BACKGROUND: This study aimed to evaluate the variation in cervical cancer glucose
metabolism for different tumor histologies and levels of differentiation, as measured by the …

BACKGROUND. The objective of this study was to evaluate cervical tumor uptake of F‐18
fluorodeoxyglucose (FDG) measured as the maximal standardized uptake value (SUVmax) …

PURPOSE.: We evaluated the prognostic significance of tumor metabolic activity on
pretreatment positron emission tomography using the glucose analog F-18 …

Purpose: Chemoradiotherapy for locally advanced cervical cancer fails in over a third of
patients. Biomarkers with therapeutic implications are therefore needed. We investigated the …

This prospective study investigates the relationship between glucose transporter-1 (Glut-1)
expression and PET images using 18F-FDG and its uptake and compares them with the …

Background The aim of this study was to explore the association between 2-deoxy-2-F18-
fluoro-D-glucose uptake and the expressions of glucose transporter type 1 (GLUT-1) and …

Objective We analyzed the correlation of 18F-fluorodeoxyglucose (FDG) uptake into primary
tumors using the maximum standardized uptake value (SUVmax) and clinicopathological …

PURPOSE: To document changes in cervical tumor 18-F-fluorodeoxyglocose (FDG) uptake
during radiation therapy and to correlate those changes with post-treatment tumor response …

Objective: We investigated the prognostic value of intratumoral [18F] fluorodeoxyglucose
(FDG) uptake heterogeneity (IFH) derived from positron emission tomography/computed …

Objective We compared the prognostic value of volume-based metabolic parameters
determined using fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission …